1
|
Villacampa A, Alfaro E, Morales C, Díaz-García E, López-Fernández C, Bartha JL, López-Sánchez F, Lorenzo Ó, Moncada S, Sánchez-Ferrer CF, García-Río F, Cubillos-Zapata C, Peiró C. Correction: SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal 2024; 22:64. [PMID: 38263164 PMCID: PMC10807070 DOI: 10.1186/s12964-024-01491-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2024] Open
Affiliation(s)
- Alicia Villacampa
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Enrique Alfaro
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Network- Ing Center On Respiratory Diseases (CIBERES), Madrid, Spain
| | - Cristina Morales
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Elena Díaz-García
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Network- Ing Center On Respiratory Diseases (CIBERES), Madrid, Spain
| | - Cristina López-Fernández
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
| | - José Luis Bartha
- Department of Obstetrics and Gynecology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
- Gynecology and Obstetrics Service, La Paz University Hospital, Madrid, Spain
| | | | - Óscar Lorenzo
- Laboratory of Diabetes and Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain
- Biomedical Research Networking Centre On Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain
- Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Salvador Moncada
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Carlos F Sánchez-Ferrer
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
- Vascular Pharmacology and Metabolism (FARMA- VASM) Group, IdiPAZ, Madrid, Spain
| | - Francisco García-Río
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Network- Ing Center On Respiratory Diseases (CIBERES), Madrid, Spain
- Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Carolina Cubillos-Zapata
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.
- Biomedical Research Network- Ing Center On Respiratory Diseases (CIBERES), Madrid, Spain.
| | - Concepción Peiró
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Vascular Pharmacology and Metabolism (FARMA- VASM) Group, IdiPAZ, Madrid, Spain.
| |
Collapse
|
2
|
Villacampa A, Alfaro E, Morales C, Díaz-García E, López-Fernández C, Bartha JL, López-Sánchez F, Lorenzo Ó, Moncada S, Sánchez-Ferrer CF, García-Río F, Cubillos-Zapata C, Peiró C. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal 2024; 22:38. [PMID: 38225643 PMCID: PMC10788971 DOI: 10.1186/s12964-023-01397-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Accepted: 11/12/2023] [Indexed: 01/17/2024] Open
Abstract
BACKGROUND Hyperinflammation, hypercoagulation and endothelial injury are major findings in acute and post-COVID-19. The SARS-CoV-2 S protein has been detected as an isolated element in human tissues reservoirs and is the main product of mRNA COVID-19 vaccines. We investigated whether the S protein alone triggers pro-inflammatory and pro-coagulant responses in primary cultures of two cell types deeply affected by SARS-CoV-2, such are monocytes and endothelial cells. METHODS In human umbilical vein endothelial cells (HUVEC) and monocytes, the components of NF-κB and the NLRP3 inflammasome system, as well as coagulation regulators, were assessed by qRT-PCR, Western blot, flow cytometry, or indirect immunofluorescence. RESULTS S protein activated NF-κB, promoted pro-inflammatory cytokines release, and triggered the priming and activation of the NLRP3 inflammasome system resulting in mature IL-1β formation in both cell types. This was paralleled by enhanced production of coagulation factors such as von Willebrand factor (vWF), factor VIII or tissue factor, that was mediated, at least in part, by IL-1β. Additionally, S protein failed to enhance ADAMTS-13 levels to counteract the pro-coagulant activity of vWF multimers. Monocytes and HUVEC barely expressed angiotensin-converting enzyme-2. Pharmacological approaches and gene silencing showed that TLR4 receptors mediated the effects of S protein in monocytes, but not in HUVEC. CONCLUSION S protein behaves both as a pro-inflammatory and pro-coagulant stimulus in human monocytes and endothelial cells. Interfering with the receptors or signaling pathways evoked by the S protein may help preventing immune and vascular complications driven by such an isolated viral element. Video Abstract.
Collapse
Affiliation(s)
- Alicia Villacampa
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Enrique Alfaro
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain
| | - Cristina Morales
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Elena Díaz-García
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain
| | - Cristina López-Fernández
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
| | - José Luis Bartha
- Department of Obstetrics and Gynecology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
- Gynecology and Obstetrics Service, La Paz University Hospital, Madrid, Spain
| | | | - Óscar Lorenzo
- Laboratory of Diabetes and Vascular pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain
- Biomedical Research Networking Centre on Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain
- Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Salvador Moncada
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Carlos F Sánchez-Ferrer
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
- Vascular Pharmacology and Metabolism (FARMAVASM) group, IdiPAZ, Madrid, Spain
| | - Francisco García-Río
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain
- Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain
- Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
| | - Carolina Cubillos-Zapata
- Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.
- Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
| | - Concepción Peiró
- Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Vascular Pharmacology and Metabolism (FARMAVASM) group, IdiPAZ, Madrid, Spain.
| |
Collapse
|
3
|
Sinha R, Masina R, Morales C, Burton K, Wan Y, Joannides A, Mair RJ, Morris RC, Santarius T, Manly T, Price SJ. A Prospective Study of Longitudinal Risks of Cognitive Deficit for People Undergoing Glioblastoma Surgery Using a Tablet Computer Cognition Testing Battery: Towards Personalized Understanding of Risks to Cognitive Function. J Pers Med 2023; 13:jpm13020278. [PMID: 36836511 PMCID: PMC9967594 DOI: 10.3390/jpm13020278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 01/26/2023] [Accepted: 01/30/2023] [Indexed: 02/04/2023] Open
Abstract
Glioblastoma and the surgery to remove it pose high risks to the cognitive function of patients. Little reliable data exist about these risks, especially postoperatively before radiotherapy. We hypothesized that cognitive deficit risks detected before surgery will be exacerbated by surgery in patients with glioblastoma undergoing maximal treatment regimens. We used longitudinal electronic cognitive testing perioperatively to perform a prospective, longitudinal, observational study of 49 participants with glioblastoma undergoing surgery. Before surgery (A1), the participant risk of deficit in 5/6 cognitive domains was increased compared to normative data. Of these, the risks to Attention (OR = 31.19), Memory (OR = 97.38), and Perception (OR = 213.75) were markedly increased. These risks significantly increased in the early period after surgery (A2) when patients were discharged home or seen in the clinic to discuss histology results. For participants tested at 4-6 weeks after surgery (A3) before starting radiotherapy, there was evidence of risk reduction towards A1. The observed risks of cognitive deficit were independent of patient-specific, tumour-specific, and surgery-specific co-variates. These results reveal a timeframe of natural recovery in the first 4-6 weeks after surgery based on personalized deficit profiles for each participant. Future research in this period could investigate personalized rehabilitation tools to aid the recovery process found.
Collapse
Affiliation(s)
- Rohitashwa Sinha
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
- Leeds Institute of Medical Research, University of Leeds, Leeds LS9 7TF, UK
- Correspondence:
| | - Riccardo Masina
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
| | - Cristina Morales
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
| | - Katherine Burton
- Department of Oncology, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
| | - Yizhou Wan
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Alexis Joannides
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Richard J. Mair
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
| | - Robert C. Morris
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
| | - Thomas Santarius
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
| | - Tom Manly
- MRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK
| | - Stephen J. Price
- Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
| |
Collapse
|
4
|
De La Torre-Fernandez De Vega J, Valles E, Barberan L, Pancorbo M, Comas M, Garrido A, Hernan I, Vives I, Rivero J, Morales C, Siso C, Cruella M, Balmaña J, Gil-Moreno A, Espinosa Bravo M. Risk factors of complications after nipple-sparing mastectomies in women with breast cancer risk gene mutations (BRCA1, BRCA2, PALB2). Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01465-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
5
|
Siso C, Rivero J, Morales C, De la Torre J, Vives I, Rodriguez-Arana A, Miranda I, Rus M, Espinosa-Bravo M. Initial experience with targeted axillary dissection (TAD) guided by ultrasound in early-stage node positive breast cancer patients undergoing upfront surgery. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01414-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
6
|
Moreno-Arrones O, Rodrigues-Barata R, Morales C, Imbernon-Moya A, Saceda-Corralo D, Matji A, Vañó-Galván S. Serious Adverse effects From Compounding Errors With Low-Dose Oral Minoxidil for Alopecia Treatment. Actas Dermo-Sifiliográficas 2022; 113:725-727. [DOI: 10.1016/j.ad.2021.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 02/23/2021] [Accepted: 03/01/2021] [Indexed: 10/19/2022] Open
|
7
|
Moreno-Arrones O, Rodrigues-Barata R, Morales C, Imbernon-Moya A, Saceda-Corralo D, Matji A, Vañó-Galván S. [Artículo traducido] Efectos adversos graves por errores de formulación de minoxidil oral a bajas dosis para el tratamiento de la alopecia. Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2021.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Undurraga P, Morales C, Samano M, Jaen MW, Fernandes L, Dreyse J, Fernandes PP. Lung Transplantation for Post COVID19 End Stage Lung Failure: A Case Series from 3 Latin American Countries. J Heart Lung Transplant 2022. [PMCID: PMC8988753 DOI: 10.1016/j.healun.2022.01.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
9
|
Finocchietto P, Perez H, Blanco G, Miksztowicz V, Marotte C, Morales C, Peralta J, Berg G, Poderoso C, Poderoso JJ, Carreras MC. Inhibition of Mitochondrial Fission by Drp-1 Blockade by Short-Term Leptin and Mdivi-1 Treatment Improves White Adipose Tissue Abnormalities in Obesity and Diabetes. Pharmacol Res 2021; 178:106028. [PMID: 34896541 DOI: 10.1016/j.phrs.2021.106028] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 11/25/2021] [Accepted: 12/06/2021] [Indexed: 01/11/2023]
Abstract
BACKGROUND Obesity and type 2 diabetes are chronic diseases characterized by insulin resistance, mitochondrial dysfunction and morphological abnormalities. OBJECTIVE We have investigated if dysregulation of mitochondrial dynamics and biogenesis is involved in an animal model of obesity and diabetes. METHODS The effect of short-term leptin and mdivi-1 -a selective inhibitor of Drp-1 fission-protein- treatment on mitochondrial dynamics and biogenesis was evaluated in epididymal white adipose tissue (WAT) from male ob/ob mice. RESULTS An increase in Drp-1 protein levels and a decrease in Mfn2 and OPA-1 protein expression were observed with enhanced and sustained mitochondrial fragmentation in ob/ob mice compared to wt C57BL/6 animals (p<0.05). The content of mitochondrial DNA and PGC-1α mRNA expression -both parameters of mitochondrial biogenesis- were reduced in ob/ob mice (p<0.05). Treatment with leptin and mdivi-1 significantly increased mitochondrial biogenesis, improved fusion-to-fission balance and attenuated mitochondrial dysfunction, thus inducing white-to-beige adipocyte transdifferentiation. Measurements of glucose and lipid oxidation in adipocytes revealed that both leptin and mdivi-1 increase substrates oxidation while in vivo determination of blood glucose concentration showed decreased levels by 50% in ob/ob mice, almost to the wt level. CONCLUSIONS Pharmacological targeting of Drp-1 fission protein may be a potential novel therapeutic tool for obesity and type 2 diabetes.
Collapse
Affiliation(s)
- P Finocchietto
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina; Departamento de Medicina, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
| | - H Perez
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina
| | - G Blanco
- Laboratorio de Inmunotoxicología (LaITo), IDEHU-CONICET, Universidad de Buenos Aires, Argentina
| | - V Miksztowicz
- Facultad de Medicina, Pontificia Universidad Católica Argentina (UCA), Instituto de Investigaciones Biomédicas (UCA-CONICET), Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Buenos Aires, Argentina; Laboratorio de Lípidos y Aterosclerosis, Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Universidad de Buenos Aires, Buenos Aires, Argentina
| | - C Marotte
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina
| | - C Morales
- Departamento de Patología, Facultad de Medicina, Instituto de Fisiopatología Cardiovascular, Universidad de Buenos Aires, Argentina
| | - J Peralta
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina; Departamento de Medicina, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - G Berg
- Laboratorio de Lípidos y Aterosclerosis, Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Universidad de Buenos Aires, Buenos Aires, Argentina
| | - C Poderoso
- Departamento de Bioquímica Humana, Facultad de Medicina, Universidad de Buenos Aires, Argentina
| | - J J Poderoso
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina
| | - M C Carreras
- Laboratorio de Metabolismo del Oxígeno INIGEM-UBA-CONICET, Buenos Aires, Argentina
| |
Collapse
|
10
|
Morales C, Solís S, Bacame-Valenzuela F, Reyes-Vidal Y, Cárdenas J, Manríquez J, Bustos E. Electrical stimulation of Cucumis sativus in an Antrosol using modified electrodes with transition metal oxides at the in situ pilot level. J Electroanal Chem (Lausanne) 2021. [DOI: 10.1016/j.jelechem.2021.115528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Cerezo-Navarrete C, Mathieu Y, Puche M, Morales C, Concepción P, Martínez-Prieto LM, Corma A. Controlling the selectivity of bimetallic platinum–ruthenium nanoparticles supported on N-doped graphene by adjusting their metal composition. Catal Sci Technol 2021. [DOI: 10.1039/d0cy02379e] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Bimetallic platinum–ruthenium nanoparticles supported on N-doped graphene as chemoselective hydrogenation catalysts.
Collapse
Affiliation(s)
| | - Yannick Mathieu
- ITQ, Instituto de Tecnología Química
- Universitat Politècnica de València (UPV)
- Valencia
- Spain
| | - Marta Puche
- ITQ, Instituto de Tecnología Química
- Universitat Politècnica de València (UPV)
- Valencia
- Spain
| | - Cristina Morales
- ITQ, Instituto de Tecnología Química
- Universitat Politècnica de València (UPV)
- Valencia
- Spain
| | - Patricia Concepción
- ITQ, Instituto de Tecnología Química
- Universitat Politècnica de València (UPV)
- Valencia
- Spain
| | | | - Avelino Corma
- ITQ, Instituto de Tecnología Química
- Universitat Politècnica de València (UPV)
- Valencia
- Spain
| |
Collapse
|
12
|
Pedraja J, Maestre J, Rabanal J, Morales C, Aparicio J, del Moral I. Role of 3D printing in the protection of surgical and critical care professionals in the COVID-19 pandemic. Revista Española de Anestesiología y Reanimación (English Edition) 2020. [PMCID: PMC7546187 DOI: 10.1016/j.redare.2020.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
13
|
Pedraja J, Maestre JM, Rabanal JM, Morales C, Aparicio J, Del Moral I. Role of 3D printing for the protection of surgical and critical care professionals in the COVID-19 pandemic. ACTA ACUST UNITED AC 2020; 67:417-424. [PMID: 32891414 PMCID: PMC7418764 DOI: 10.1016/j.redar.2020.07.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 07/12/2020] [Accepted: 07/13/2020] [Indexed: 11/21/2022]
Abstract
Antecedentes y objetivo Durante la pandemia de COVID-19 se produce una reducción del material para la protección de los profesionales. La impresión 3D ofrece la posibilidad de compensar la escasez de algunos de los suministros. El objetivo es describir el papel de la impresión 3D en un servicio de salud durante la pandemia de COVID-19, con énfasis en proceso para desarrollar un producto final listo para ser implementado en el entorno clínico. Materiales y métodos Se formó un grupo de trabajo entre la administración sanitaria, clínicos y otras instituciones público-privadas de Cantabria coordinado en el Hospital virtual Valdecilla. El proceso incluyó la recepción de las propuestas de impresión, el conocimiento de los recursos de impresión en la región, la selección de los dispositivos, la creación de un equipo para cada proyecto, diseño de prototipos, evaluación y rediseño, fabricación montaje y distribución. Resultados Se producen 1) dispositivos que ayudan a prevenir el contagio de los profesionales: pantallas de protección facial (2.400 unidades), accesorios personalizados para fotóforos (20 unidades) y horquillas salvaorejas para mascarillas (1.200 unidades); 2) productos relacionados con la ventilación de pacientes infectados: conectores de sistemas de ventilación no invasiva entre tubuladura y mascarilla; y 3) hisopos oro y nasofaríngeos (7.500 unidades) para la identificación de portadoras del coronavirus con el objetivo de diseñar protocolos de actuación en las área clínicas. Conclusiones La impresión 3D es un recurso válido para la producción de material de protección de los profesionales cuyo suministro está reducido durante una pandemia.
Collapse
Affiliation(s)
- J Pedraja
- Hospital virtual Valdecilla, Santander, España
| | - J M Maestre
- Hospital virtual Valdecilla, Santander, España; Servicio de Anestesiología y Reanimación, Hospital Universitario Marqués de Valdecilla, Santander, España.
| | - J M Rabanal
- Hospital virtual Valdecilla, Santander, España; Servicio de Anestesiología y Reanimación, Hospital Universitario Marqués de Valdecilla, Santander, España
| | - C Morales
- Hospital virtual Valdecilla, Santander, España; Servicio de Otorrinolaringología, Hospital Universitario Marqués de Valdecilla, Santander, España
| | - J Aparicio
- Prevención de Riesgos, Hospital Universitario Marqués de Valdecilla, Santander, España
| | - I Del Moral
- Hospital virtual Valdecilla, Santander, España
| |
Collapse
|
14
|
Luque L, Rodrigo T, García-García JM, Casals M, Millet JP, Caylà J, Orcau A, Agüero R, Alcázar J, Altet N, Altube L, Álvarez F, Anibarro L, Barrón M, Bermúdez P, Bikuña E, Blanquer R, Borderías L, Bustamante A, Calpe J, Caminero J, Cañas F, Casas F, Casas X, Cases E, Castejón N, Castrodeza R, Cebrián J, Cervera A, Ciruelos J, Delgado A, De Souza M, Díaz D, Domínguez M, Fernández B, Gallardo J, Gallego M, Clemente MG, García C, García F, Garros F, Gort A, Guerediaga A, Gullón J, Hidalgo C, Iglesias M, Jiménez G, Jiménez M, Kindelan J, Laparra J, López I, Lera R, Lloret T, Marín M, Lacasa XM, Martínez E, Martínez A, Medina J, Melero C, Milà C, Millet J, Mir I, Molina F, Morales C, Morales M, Moreno A, Moreno V, Muñoz A, Muñoz C, Muñoz J, Muñoz L, Oribe M, Parra I, Penas A, Pérez J, Rivas P, Rodríguez J, Ruiz-Manzano J, Sala J, Sandel D, Sánchez M, Sánchez M, Sánchez P, Santamaría I, Sanz F, Serrano A, Somoza M, Tabernero E, Trujillo E, Valencia E, Valiño P, Vargas A, Vidal I, Vidal R, Villanueva M, Villar A, Vizcaya M, Zabaleta M, Zubillaga G. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population. Open Respiratory Archives 2020. [DOI: 10.1016/j.opresp.2020.04.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
|
15
|
Astroza G, Morales C, Saez G. As little as possible. A new paradigm in endourology. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33843-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
16
|
Pérez-Ruiz E, Jiménez-Castro J, Berciano-Guerrero MA, Valdivia J, Estalella-Mendoza S, Toscano F, Rodriguez de la Borbolla Artacho M, Garrido-Siles M, Martínez-Bautista MJ, Villatoro Roldan R, Rivas-Ruiz F, Nogales-Fernández E, Morales C, Pérez-Valderrama B, De la Cruz-Merino L, Rueda A. Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. Clin Transl Oncol 2020; 22:1778-1785. [DOI: 10.1007/s12094-020-02315-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2019] [Accepted: 01/31/2020] [Indexed: 02/04/2023]
|
17
|
Díaz-Redondo T, Lavado-Valenzuela R, Jimenez B, Pascual T, Gálvez F, Falcón A, Alamo MDC, Morales C, Amerigo M, Pascual J, Sanchez-Muñoz A, González-Guerrero M, Vicioso L, Laborda A, Ortega MV, Perez L, Fernandez-Martinez A, Chic N, Jerez JM, Alvarez M, Prat A, Ribelles N, Alba E. Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data. Front Oncol 2019; 9:1178. [PMID: 31750258 PMCID: PMC6848376 DOI: 10.3389/fonc.2019.01178] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Accepted: 10/18/2019] [Indexed: 01/09/2023] Open
Abstract
Background: Double blockade with pertuzumab and trastuzumab combined with chemotherapy is the standard neoadjuvant treatment for HER2-positive early breast cancer. Data derived from clinical trials indicates that the response rates differ among intrinsic subtypes of breast cancer. The aim of this study is to determine if these results are valid in real-world patients. Methods: A total of 259 patients treated in eight Spanish hospitals were included and divided into two cohorts: Cohort A (132 patients) received trastuzumab plus standard neoadjuvant chemotherapy (NAC), and Cohort B received pertuzumab and trastuzumab plus NAC (122 patients). Pathological complete response (pCR) was defined as the complete disappearance of invasive tumor cells. Assignment of the intrinsic subtype was realized using the research-based PAM50 signature. Results: There were more HER2-enriched tumors in Cohort A (70 vs. 56%) and more basal-like tumors in Cohort B (12 vs. 2%), with similar luminal cases in both cohorts (luminal A 12 vs. 14%; luminal B 14 vs. 18%). The overall pCR rate was 39% in Cohort A and 61% in Cohort B. Better pCR rates with pertuzumab plus trastuzumab than with trastuzumab alone were also observed in all intrinsic subtypes (luminal PAM50 41 vs. 11.4% and HER2-enriched subtype 73.5 vs. 50%) but not in basal-like tumors (53.3 vs. 50%). In multivariate analysis the only significant variables related to pCR in both luminal PAM50 and HER2-enriched subtypes were treatment with pertuzumab plus trastuzumab (Cohort B) and histological grade 3. Conclusions: With data obtained from patients treated in clinical practice, it has been possible to verify that the addition of pertuzumab to trastuzumab and neoadjuvant chemotherapy substantially increases the rate of pCR, especially in the HER2-enriched subtype but also in luminal subtypes, with no apparent benefit in basal-like tumors.
Collapse
Affiliation(s)
- Tamara Díaz-Redondo
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Rocio Lavado-Valenzuela
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain
| | - Begoña Jimenez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Tomas Pascual
- Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | - Alfonso Sanchez-Muñoz
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | | | - Luis Vicioso
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Anatomía Patológica Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Aurora Laborda
- Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain
| | - Maria Victoria Ortega
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Anatomía Patológica Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Lidia Perez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Anatomía Patológica Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Aranzazu Fernandez-Martinez
- Lineberger Comprehensive Cancer Center, University of North Caroina at Chapel Hill, Chapel Hill, NC, United States
| | - Nuria Chic
- Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain
| | - Jose Manuel Jerez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Departamento de Lenguajes y Ciencias de la Computación, Universidad de Málaga, Málaga, Spain
| | - Martina Alvarez
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain
- Unidad de Gestión Clínica Anatomía Patológica Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Aleix Prat
- Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain
| | - Nuria Ribelles
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
| | - Emilio Alba
- Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Unidad de Gestión Clínica Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
- Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain
| |
Collapse
|
18
|
Gonzalez G, Cassaglia PD, Penas F, Martinez NL, Bettazza C, Wilensky L, Fontana Estevez F, Noli Truant S, Miksztowicz V, Cevey A, Cicale E, Berg G, Fernandez M, Goren N, Morales C. P6297Genetic mutation of galectin-3 altered the temporal evolution of macrophage polarization and healing affecting the post myocardial infarct remodeling in mice. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Myocardial infarction (MI) is a dynamic process that leads to ventricular remodeling (VR) and largely to heart failure (HF). Previous studies established that Galectin-3 (Gal-3) is highly increased in the infarct zone from the beginning of MI and also that it is a prognostic marker of HF.
Purpose
We aimed to study the effects of genetic deletion of Gal-3 on macrophage (MΦ) infiltration, cytokines expression, fibrosis and MMP-2 activity as well as VR and function after MI in mice.
Methods
Male C57BL/6J and Gal-3 KO mice were subjected to permanent coronary ligature or sham. At 1 week post-MI LV function and VR were studied by echocardiography. We also studied in the infarct zone: 1) F4/80+ MΦ infiltration by flow cytometry; 2) M2 macrophage polarization by detection of mannose receptor (MR) and chitinase-3-like protein-3 (YM1) phenotype markers by rt-qPCR; 3) mRNA expression of TNF-α, IL-6, IL-10 and TGF-β; 4) MMP-2 activity by zymography and 5) fibrosis by histology.
Results
Results are expressed as X±SEM; *p<0.05 C57 MI vs Gal-3 KO MI. After 1 week post-MI, the pulmonary congestion assessed by the lung weight/body weight ratio (mg/g) was 9±0.4, 8±0.5 and 9±0.4 in C57 sham, Gal-3 KO sham and C57 MI, respectively, nevertheless it was severely increased to 15±1.2* in infarcted Gal-3 KO mice. MΦ infiltration, cytokine expression and MMP-2 activity in the infarct zone are shown in the table.
Table 1 Groups F4/80+ MR YM1 TNF-α IL-6 IL-10 TGF-β MMP-2 MΦ (%) (A.U.) (A.U.) (A.U.) (A.U.) (A.U.) (A.U.) (A.U.) C57 MI 5.6±0.9 (8) 0.5±0.2 (3) 1.7±0.4 (3) 26±0.3 (3) 1.7±0.5 (3) 0.7±0.03 (3) 1.8±0.5 (3) 1±0.1 (5) Gal-3 KO MI 2.6±0.4* (8) 1.8±0.4*(8) 4.2±0.4* (8) 0.4±0.5* (8) 6.7±0.9 * (8) 2.8±0.3 * (8) 0.5±0.2 * (8) 2±0.4* (6) A.U.: Arbitrary units. In MR, YM1, TNF-α, IL-6, IL-10 and TGF-β represent mRNA expression. In MMP-2 represent gelatinolytic activity. Number of samples is shown between parentheses.
After 1 week post-MI, LV end diastolic dimension was increased from 4.4±0.1 to 4.8±0.2* at the same time that ejection fraction (%) was significantly reduced from 47±2 to 38±3* in C57+MI (13) and Gal-3 KO+MI (16) respectively. Collagen concentration in the infarct zone was significantly reduced from 30±1.2% (6) to 17±0.5* % (8) in C57 and Gal-3 KO respectively.
Conclusion(s)
Gal-3 is an essential regulatory factor for the early wound healing since it regulates the dynamics of the reparative process through the phenotypic profile of MΦ, the pro- and anti-inflammatory cytokines expression and fibrosis along the temporal evolution of MI in mice. The deficit of Gal-3 diminished the infiltration of MΦ altering its phenotypic polarization and consequently, the dynamics of the wound healing as well as aggravating the functional and structural evolution of cardiac remodeling.
Acknowledgement/Funding
Argentine Agency for Promotion of Science and Technology (PICT 2014-2320), University of Buenos Aires (UBACyT 20020170100619BA)
Collapse
Affiliation(s)
- G Gonzalez
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| | - P D Cassaglia
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| | - F Penas
- University of Buenos Aires, Institute of Biomedical Research in Retrovirus and Aids, Capital Federal, Argentina
| | - N L Martinez
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| | - C Bettazza
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| | - L Wilensky
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| | - F Fontana Estevez
- Pontifical Catholic University of Argentina, Biomedical Research Institute (BIOMED), Capital Federal, Argentina
| | - S Noli Truant
- University of Buenos Aires, Institute for studies of humoral immunity, Buenos Aires, Argentina
| | - V Miksztowicz
- University of Buenos Aires. Faculty of Pharmacy and Biochemistry, Lipids Laboratory, Capital Federal, Argentina
| | - A Cevey
- University of Buenos Aires, Institute of Biomedical Research in Retrovirus and Aids, Capital Federal, Argentina
| | - E Cicale
- University of Buenos Aires. Faculty of Veterinary, bioresources, Capital Federal, Argentina
| | - G Berg
- University of Buenos Aires. Faculty of Pharmacy and Biochemistry, Lipids Laboratory, Capital Federal, Argentina
| | - M Fernandez
- University of Buenos Aires, Institute for studies of humoral immunity, Buenos Aires, Argentina
| | - N Goren
- University of Buenos Aires, Institute of Biomedical Research in Retrovirus and Aids, Capital Federal, Argentina
| | - C Morales
- University of Buenos Aires-CONICET. Faculty of Medicine, Institute of Cardiovascular Pathophysiology, Pathology, Capital Federal, Argentina
| |
Collapse
|
19
|
Ciruelos EM, Díaz MN, Isla MD, López R, Bernabé R, González E, Cirauqui B, Coves J, Morales S, Arcediano A, Barneto I, Cerezuela P, Illarramendi JJ, Morales C, Ponce S. Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. Eur J Cancer Care (Engl) 2019; 28:e13164. [PMID: 31571304 DOI: 10.1111/ecc.13164] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2017] [Revised: 10/31/2018] [Accepted: 04/17/2019] [Indexed: 12/29/2022]
Abstract
OBJECTIVES Although new therapies against metastatic cancer have been developed in recent decades, chemotherapy is still an important treatment option. Prolonged treatment and side-effects are often discouraging for patients, and in many cases, therapy is only palliative, not curative. This study explores patient preference for oral or intravenous (IV) chemotherapy in the treatment of metastatic breast or lung cancer. METHODS It is a descriptive, open label, multicentre, nation-wide study, in which a 16-item questionnaire consisting of single-choice questions scored on a 5-point Likert scale was administered to patients in a single visit, and another 11-item questionnaire was self-administered by the patient's oncologist. RESULTS A total of 131 breast and lung cancer specialists at 64 hospitals enrolled 412 patients (lung cancer = 161; breast cancer = 251). To be eligible, patients must have already received IV therapy and at least 2 cycles of oral chemotherapy. Most (77%) patients expressed preference for oral therapy. Most considered their daily life was less disrupted with tablets (70.4%), had no trouble swallowing them (86.9%), and were not concerned about forgetting to take them (56.8%). Half (56.3%) were worried about problems related to drug infusion with IV therapy, 61.7% were concerned about nurses failing to find a suitable vein, and 63.1% were dissatisfied with hospital waiting times. A uniform response was obtained from both samples of patients. CONCLUSION Convenience, ease of administration, fewer side effects and better quality of life tilt the balance towards oral drug administration.
Collapse
Affiliation(s)
| | | | | | - Rafael López
- Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | - Reyes Bernabé
- Hospital Universitario Nuestra Señora del Rocío, Seville, Spain
| | | | | | - Juan Coves
- Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain
| | | | | | | | - Pablo Cerezuela
- Hospital General Universitario Santa Lucía, Cartagena, Spain
| | | | | | | |
Collapse
|
20
|
Kaplan V, Morales C, Bobadilla F, Fernández J, Segovia L, Vera V, Sanhueza I. Epidemiologic and Histopathologic Characterization of Cutaneous Metastases in Patients Who Visited 2 Hospitals in Santiago de Chile Between 2005 and 2017. Actas Dermo-Sifiliográficas (English Edition) 2019. [DOI: 10.1016/j.adengl.2019.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
21
|
Gaytan F, Morales C, Roa J, Tena-Sempere M. Changes in keratin 8/18 expression in human granulosa cell lineage are associated to cell death/survival events: potential implications for the maintenance of the ovarian reserve. Hum Reprod 2019; 33:680-689. [PMID: 29401296 DOI: 10.1093/humrep/dey010] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2017] [Accepted: 01/17/2018] [Indexed: 11/13/2022] Open
Abstract
STUDY QUESTION Is keratin 8/18 (K8/K18) expression linked to cell death/survival events in the human granulosa cell lineage? SUMMARY ANSWER A close association exists between changes in K8/K18 expression and cell death/survival events along the human granulosa cell lineage lifespan. WHAT IS KNOWN ALREADY In addition to their structural and mechanical functions, K8/K18 play essential roles regulating cell death, survival and differentiation in several non-gonadal epithelial tissues. Transfection of the granulosa-like tumor KGN cells with siRNA to interfere KRT8 and KRT18 expression increases FAS-mediated apoptosis, while an inverse association between K8/K18 expression and cell death has been found in the bovine antral follicles and corpus luteum. Yet, only fragmentary and inconclusive information exists regarding K8/K18 expression in the human ovary. STUDY DESIGN, SIZE, DURATION Expression of K8/K18 was assessed by immunohistochemistry at different stages of the granulosa cell lineage, from flattened granulosa cells in primordial follicles to fully luteinized granulosa-lutein cells in the corpus luteum (including corpus luteum of pregnancy). PARTICIPANTS/MATERIALS, SETTING, METHODS Immunohistochemical detection of K8/K18 was conducted in 40 archival ovarian samples from women aged 17-39 years. K8/K18 expression was analyzed at the different stages of follicle development and corpus luteum lifespan. The proportions of primordial follicles showing all K8/K18-positive, all K8/K18 negative, or a mixture of K8/K18 negative and positive granulosa cells were quantified in 18 ovaries, divided into three age groups: ≤ 25 years (N = 6), 26-30 (N = 6) and 31-36 (N = 6) years. A total number of 1793 primordial, 750 transitional and 140 primary follicles were scored. MAIN RESULTS AND THE ROLE OF CHANCE A close association was found between changes in K8/K18 expression and cell death/cell survival events in the human granulosa cell lineage. Large secondary and early antral follicles (most of them undergoing atresia) and regressing corpora lutea displayed low/absent K8/K18 expression. Conversely, early growing and some large antral follicles, functional menstrual corpora lutea, as well as life-extended corpus luteum of pregnancy, in which cell death was scarce, showed high K8/K18 expression. Three sub-populations of primordial follicles were observed with respect to the presence of K8/K18 in their flattened granulosa cells, ranging from primordial follicles showing only positive granulosa cells [P0(+)], to others with a mixture of positive and negative cells [P0(+/-)] or follicles with only negative cells [P0(-)]. Significant age-related changes were found in the proportions of the different primordial follicle types. In relation to age, a positive correlation was found for P0(+) primordial follicles (R2= 0.7883, N = 18; P < 0.001), while negative correlations were found for P0(+/-) (R2 = 0.6853, N = 18; P < 0.001) and P0(-) (R2 = 0.6725, N = 18; P < 0.001) follicles. Furthermore, an age-related shift towards greater keratin expression was found in P0(+/-) follicles (χ2 = 19.07, P < 0.05). LARGE SCALE DATA N/A. LIMITATIONS REASONS FOR CAUTION This is a descriptive study. Hence, a cause-and-effect relationship between K8/K18 expression and cell death/survival cannot be directly established. WIDER IMPLICATIONS OF THE FINDINGS This study describes, for the first time, the existence of sub-populations of primordial follicles on the basis of K8/K18 expression in granulosa cells, and that their proportions change with age. While a progressive increase in K8/K18 expression cannot be ruled out, our data are consistent with the hypothesis that primordial follicles expressing low levels of K8/K18 are preferentially ablated by follicle attrition, while primordial follicles showing high K8/K18 levels are those predominantly recruited into the growing pool. This suggests that K8/K18 expression could constitute a novel factor regulating primordial follicle death/survival, and raises the possibility that alterations of K8/K18 expression could be involved in the accelerated depletion of the ovarian reserve leading to premature ovarian insufficiency. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by Grants BFU2011-025021 and BFU2014-57581-P (Ministerio de Economía y Competitividad, Spain; co-funded with EU funds from FEDER Program); project PIE14-00005 (Flexi-Met, Instituto de Salud Carlos III, Ministerio de Sanidad, Spain); Projects P08-CVI-03788 and P12-FQM-01943 (Junta de Andalucía, Spain); and EU research contract DEER FP7-ENV-2007-1. CIBER Fisiopatología de la Obesidad y Nutrición is an initiative of Instituto de Salud Carlos III. The authors have nothing to disclose in relation to the contents of this study.
Collapse
Affiliation(s)
- F Gaytan
- Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain
| | - C Morales
- Department of Pathology, University of Cordoba, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain
| | - J Roa
- Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain
| | - M Tena-Sempere
- Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain.,FiDiPro Program, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
| |
Collapse
|
22
|
Toro-Ibacache V, Ugarte F, Morales C, Eyquem A, Aguilera J, Astudillo W. Dental malocclusions are not just about small and weak bones: assessing the morphology of the mandible with cross-section analysis and geometric morphometrics. Clin Oral Investig 2019; 23:3479-3490. [PMID: 30604093 DOI: 10.1007/s00784-018-2766-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2018] [Accepted: 12/04/2018] [Indexed: 12/26/2022]
Abstract
OBJECTIVES Dental malocclusions in modern populations would be the result of small and weak jaws developing under low masticatory loads. We assess the validity of this by characterising the external and internal morphology of mandibles affected by class II and III malocclusions and comparing them with those from individuals with different masticatory load patterns. MATERIALS AND METHODS CTs from up to 118 individuals exerting intensive, medium and low masticatory loads with harmonic occlusion, and from class II and III individuals, were used to compare their external shape using geometric morphometrics, as well as their internal amount and distribution of cortical bone. RESULTS The low-load groups (harmonic, class II and III occlusion) are externally more gracile than the intense and medium load groups. But more relevant in shape variation is a marked allometric pattern, which differentiates class II (small) and III (large) mandibles. Despite gracility, the relative amount of cortical bone in the low-load groups is larger than in the remaining groups. CONCLUSIONS There is no evidence that the modern mandible, including class II and III individuals, is intrinsically small and weak. Instead, there is a rather large degree of morphological variation, which could be linked to a lack of constraints derived from low masticatory loads. Thus, the effect of other factors such as genetics, but also basal metabolism, should be looked in more depth. CLINICAL RELEVANCE Dental malocclusions are a common disorder whose aetiology has not been unravelled, and several to be considered in the prevention and therapy of malocclusion.
Collapse
Affiliation(s)
- Viviana Toro-Ibacache
- Centro de Análisis Cuantitativo en Antropología Dental and Instituto de Investigación en Ciencias Odontológicas, Facultad de Odontología, Universidad de Chile, Olivos 943, Independencia, Santiago, Chile. .,Department of Human Evolution, Mac Planck Institute for Evolutionary Anthropology, Deutscher Platz 6, 04103, Leipzig, Germany.
| | - Francisco Ugarte
- Centro de Análisis Cuantitativo en Antropología Dental, Facultad de Odontología, Universidad de Chile, Santiago, Chile
| | - Cristina Morales
- Centro de Análisis Cuantitativo en Antropología Dental, Facultad de Odontología, Universidad de Chile, Santiago, Chile
| | - Andrea Eyquem
- Departamento de Antropología, Facultad de Ciencias Sociales, Universidad de Chile, Santiago, Chile.,Max Planck Weizmann Center for Integrative Archaeology and Anthropology, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany
| | - José Aguilera
- Facultad de Medicina and Hospital Clínico, Universidad de Chile, Santiago, Chile
| | - Williams Astudillo
- Facultad de Medicina and Hospital Clínico, Universidad de Chile, Santiago, Chile
| |
Collapse
|
23
|
Kaplan V, Morales C, Bobadilla F, Fernández J, Segovia L, Vera V, Sanhueza I. Epidemiologic and Histopathologic Characterization of Cutaneous Metastases in Patients Who Visited 2 Hospitals in Santiago de Chile Between 2005 and 2017. Actas Dermosifiliogr (Engl Ed) 2018; 110:220-226. [PMID: 30577946 DOI: 10.1016/j.ad.2018.07.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Revised: 06/12/2018] [Accepted: 07/15/2018] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND AND OBJECTIVE Cutaneous metastases (CMs) account for 2% of skin tumors and their incidence varies between 0.7% and 9% in patients with cancer. The objective of this study was to describe and analyze the demographic, clinical, and histopathologic characteristics of CM in patients who visited 2 hospitals in the Santiago de Chile metropolitan region. MATERIAL AND METHOD We performed a retrospective, descriptive, analytical, observational, cross-sectional study. We reviewed the pathology reports, patient records, pathology slides, and dates of death for diagnosed cases of CM from the anatomic pathology departments of 2 hospitals in the Santiago de Chile metropolitan region between 2015 and 2017. RESULTS Ninety-six patients with CM were included in the study; 60.42% were women and 39.58% were men. The mean (SD) age was 67.95 (13.74) years, with a range of 28 to 96 years. The most common primary tumor was melanoma in 27.08% of cases (n=26), followed by breast cancer (18.75%, n=18), and adenocarcinoma (15.63%, n=15). The median time between diagnosis of the tumor and cutaneous metastasis was 9 months. Patients with CM of melanoma had a higher survival rate than patients with metastasis of other primary tumors (P<.05). A histopathologic study of 91 slides showed that diffuse infiltration of the tissue with tumor cells was the most common pattern and vascular invasion was rare. CONCLUSIONS The results are similar to those found worldwide. CM is a rare manifestation of internal tumors. It presents mainly at an advanced age and is equally prevalent in both sexes.
Collapse
Affiliation(s)
- V Kaplan
- Departamento de Dermatología y Venereología, Universidad de Chile, Santiago, Chile.
| | - C Morales
- Servicio de Anatomía Patológica, Hospital Clínico de la Universidad de Chile, Santiago, Chile
| | - F Bobadilla
- Servicio de Dermatología y Venereología, Hospital Barros Luco Trudeau, Santiago, Chile
| | - J Fernández
- Servicio de Dermatología y Venereología, Hospital San José, Santiago, Chile
| | - L Segovia
- Servicio de Anatomía Patológica, Hospital Barros Luco Trudeau, Santiago, Chile
| | - V Vera
- Departamento de Nutrición, Universidad de Chile, Santiago, Chile
| | - I Sanhueza
- Facultad de Medicina, Universidad de Chile, Santiago, Chile
| |
Collapse
|
24
|
Gomez-Peralta F, Lecube A, Fernández-Mariño A, Alonso Troncoso I, Morales C, Morales-Pérez FM, Guler I, Cadarso-Suárez C. Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain. Diabet Med 2018; 35:1605-1612. [PMID: 29943854 DOI: 10.1111/dme.13769] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/20/2018] [Indexed: 12/24/2022]
Abstract
AIMS To study the response of clinical variables (HbA1c , body weight, lipid profile and blood pressure) over 24 months of liraglutide treatment in a real-world clinical setting, and to describe the evolution of HbA1c and body weight reduction in response to liraglutide treatment by employing generalized additive mixed models (GAMMs). METHODS We included people aged ≥ 18 years with Type 2 diabetes mellitus that initiated liraglutide treatment between November 2011 and May 2015. Demographic and clinical data were retrieved retrospectively over 24 months from electronic medical records with a median duration of observation of 7.0 (IQR 3.0-12.0) months. RESULTS Individuals that initiated liraglutide therapy were obese (BMI 39.1 kg/m2 ), with inadequate HbA1c (68 mmol/mol [8.4%]), blood pressure and lipid levels. Upon liraglutide treatment, HbA1c , body weight, mean systolic and diastolic blood pressure, and lipid levels decreased gradually. GAMMs demonstrated that longer treatment with liraglutide was a predictor of improved HbA1c response, whereas higher baseline HbA1c , longer Type 2 diabetes duration and treatment with insulin were predictors of worse HbA1c response. Higher baseline weight, longer treatment with liraglutide and the interaction between metformin and time were predictors of improved weight response. CONCLUSIONS In this real-world study, we showed the effectiveness of liraglutide in improving body weight, HbA1c , mean systolic and diastolic blood pressure, and lipid levels. GAMMs indicated that baseline HbA1c and weight, time of treatment with liraglutide, diabetes duration and the use of metformin or insulin are predictors of clinical response to liraglutide.
Collapse
Affiliation(s)
- F Gomez-Peralta
- Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia
| | - A Lecube
- Endocrinology and Nutrition Unit, University Hospital Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida and CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas, ISCIII), University of Lleida, Lleida
| | | | | | - C Morales
- Endocrinology and Nutrition Unit, Virgen Macarena Hospital, Seville
| | - F M Morales-Pérez
- Endocrinology Unit, Hospital Universitario Infanta Cristina, Badajoz
| | - I Guler
- Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, A Coruña, Spain
| | - C Cadarso-Suárez
- Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, A Coruña, Spain
| |
Collapse
|
25
|
Berg G, Barchuk M, Zago V, Cevey A, Goren N, Friedman S, Morales C, Schreier L, Miksztowicz V. Is endothelial lipase a supporting actor of lipoprotein lipase in obesity? Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Catalán V, Yagnam M, Morales C, Villagra M. ¿Es el signo de Hutchinson patognomónico de melanoma subungueal? Actas Dermo-Sifiliográficas 2018; 109:573-575. [DOI: 10.1016/j.ad.2017.06.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2017] [Revised: 06/11/2017] [Accepted: 06/19/2017] [Indexed: 10/18/2022] Open
|
27
|
Catalán V, Yagnam M, Morales C, Villagra M. Is Hutchinson's Sign Pathognomic of Subungual Melanoma? Actas Dermo-Sifiliográficas (English Edition) 2018. [DOI: 10.1016/j.adengl.2018.05.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
|
28
|
Sedgwick DM, Román R, Barrio P, Morales C, Fustero S. A metal-free and regioselective approach to (Z)-β-fluorovinyl sulfones and their chemoselective hydrogenation to β-fluoroalkyl sulfones. J Fluor Chem 2018. [DOI: 10.1016/j.jfluchem.2017.12.016] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
29
|
Galeazzi R, González-Panzo IJ, Díaz-Becerril T, Morales C, Rosendo E, Silva R, Romano-Trujillo R, Coyopol A, Nieto-Caballero FG, Treviño-Yarce L. Physicochemical conditions for ZnO films deposited by microwave chemical bath deposition. RSC Adv 2018; 8:8662-8670. [PMID: 35539881 PMCID: PMC9078622 DOI: 10.1039/c8ra00065d] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Accepted: 02/16/2018] [Indexed: 12/30/2022] Open
Abstract
Physicochemical analysis was carried out to obtain the species distribution diagrams (SDDs) for the deposition of ZnO films as a function of OH− ion concentration ([OH−]) in the reaction solution. The study of SDDs predicts nucleation and ZnO film growth by means of the dominant species at a given pH value. To confirm this, a series of experiments were made varying the [OH−] in the reaction solution and keeping the others parameters constant. Structured zinc oxide (ZnO) films were obtained on glass substrates by microwave chemical bath deposition (MWCBD). Structural, optical and morphological ZnO film properties were investigated as a function of [OH−]. X-Ray diffraction technique (XRD) measurements show multiple diffraction peaks, indicating the polycrystalline nature of ZnO films. Scanning Electron Microscopy (SEM) images of ZnO structures showed morphological changes with the variation of [OH−]. The stoichiometry of the structures changed as the [OH−] was varied in solution. From Raman spectra, it was observed that the [OH−] of the reaction mixture strongly affects the crystal quality of ZnO structures. A reaction pathway for the synthesis of ZnO structures based on our results is proposed. Experimental results are consistent with the physical–chemical analysis. Physicochemical analysis was carried out to obtain the species distribution diagrams (SDDs) for the deposition of ZnO films as a function of OH− ion concentration ([OH−]) in the reaction solution.![]()
Collapse
Affiliation(s)
- R. Galeazzi
- CIDS-ICUAP
- Benemérita Universidad Autónoma de Puebla
- Puebla
- México
| | | | | | - C. Morales
- CIDS-ICUAP
- Benemérita Universidad Autónoma de Puebla
- Puebla
- México
| | - E. Rosendo
- CIDS-ICUAP
- Benemérita Universidad Autónoma de Puebla
- Puebla
- México
| | - R. Silva
- IFUAP
- Benemérita Universidad Autónoma de Puebla
- Puebla
- México
| | | | - A. Coyopol
- CIDS-ICUAP
- Benemérita Universidad Autónoma de Puebla
- Puebla
- México
| | | | | |
Collapse
|
30
|
Rad S, Beauchamp S, Morales C, Mirocha J, Esakoff TF. Defining fetal growth restriction: abdominal circumference as an alternative criterion. J Matern Fetal Neonatal Med 2017; 31:3089-3094. [PMID: 28817998 DOI: 10.1080/14767058.2017.1364723] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
PURPOSE The purpose of this study is to determine if using abdominal circumference percentile (AC) to define fetal growth restriction (FGR) improves ultrasound at ≥36 weeks as a screening test for small for gestational age (SGA). MATERIALS AND METHODS All non-anomalous singletons undergoing ultrasound at a single center at ≥36 weeks during 12/2008-5/2014 were included. FGR was defined as (estimated fetal weight) estimated fetal weight (EFW) and/or abdominal circumference (AC) < 10 for gestational age (GA). The primary outcome was SGA (birthweight ≤10th percentile for GA). Data were stratified by maternal race/ethnicity and BMI. Sensitivity, specificity, false-positive rate (FPR), positive- and negative-predictive values (positive-predictive value (PPV), negative-predictive value (NPV)), and areas under the receiver-operating characteristic (ROC) curve (AUC were calculated. RESULTS There were 1594 ultrasounds. Median (IQR) ultrasound GA was 37.3 (36.6-38.0), days to delivery 10.6 (5.0-18.4), and delivery GA 39.29 (38.6-39.9). EFW <10 had the following characteristics: sensitivity 50.6%, FPR 2.0%, PPV 83.8%, and AUC 0.743. Using AC <10, these were 64.0, 2.9, 81.3, and 0.806, respectively. Using AC or EFW <10, these were 67.5, 3.3, 80.3, and 0.821, respectively; this criterion has the largest AUC (p < .008). This finding persisted when stratified by maternal race/ethnicity and BMI. CONCLUSIONS AC <10 is more sensitive and has a similar PPV compared with EFW <10 for SGA. Using AC <10 or EFW <10 has the best balance of sensitivity and specificity as a screening test and has a low FPR. AC may be a reasonable alternative criterion to EFW for FGR diagnosis.
Collapse
Affiliation(s)
- Steve Rad
- a Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology , Cedars-Sinai Medical Center , Los Angeles , CA , USA
| | - S Beauchamp
- a Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology , Cedars-Sinai Medical Center , Los Angeles , CA , USA
| | - C Morales
- a Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology , Cedars-Sinai Medical Center , Los Angeles , CA , USA
| | - J Mirocha
- b Biostatistics Research Institute, Cedars-Sinai Medical Center , Los Angeles , CA , USA
| | - T F Esakoff
- a Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology , Cedars-Sinai Medical Center , Los Angeles , CA , USA
| |
Collapse
|
31
|
Alvarez-Perea A, Ameiro B, Morales C, Zambrano G, Rodríguez A, Guzmán M, Zubeldia JM, Baeza ML. Anaphylaxis in the Pediatric Emergency Department: Analysis of 133 Cases After an Allergy Workup. J Allergy Clin Immunol Pract 2017; 5:1256-1263. [PMID: 28389303 DOI: 10.1016/j.jaip.2017.02.011] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 01/11/2017] [Accepted: 02/17/2017] [Indexed: 11/24/2022]
Abstract
BACKGROUND Data on the incidence and characteristics of pediatric anaphylaxis are scarce. Reported causes of anaphylaxis are mostly those suspected by the physician in the emergency department (ED), which may not coincide with the real triggers. OBJECTIVES To investigate the incidence, management, and etiology of pediatric anaphylaxis in the ED of a Spanish tertiary hospital and to determine the concordance between the suspected etiology in the ED and diagnosis after the allergy workup. METHODS We performed an observational, descriptive study of all patients with anaphylaxis attended in the pediatric ED from 2012 to 2014. Cases were considered anaphylaxis based on National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria. We recorded data on clinical characteristics, management, etiology suspected by the ED physician and patient (or relatives), and the workup performed in the allergy department. RESULTS We recorded 133 cases of anaphylaxis (incidence, 0.12%), with 20 cases (15%) recorded in children younger than 12 months. Anaphylaxis was correctly diagnosed in the ED in 70 cases (53%). Food allergy was the cause of anaphylaxis in 106 out of 118 studied in the allergy department (AD) (90%). The final etiology differed from the etiology initially suspected in the ED in 42 cases (39%). After the study, the frequency of patients with unidentified triggers decreased by 75%. CONCLUSIONS The incidence of anaphylaxis is higher in children than previously reported in adults from the same center, and food is the trigger in most cases. To prevent erroneous diagnoses, the etiology of anaphylaxis should be established after an appropriate workup.
Collapse
Affiliation(s)
- Alberto Alvarez-Perea
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute, Madrid, Spain.
| | - Beatriz Ameiro
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Cristina Morales
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Gabriela Zambrano
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Ana Rodríguez
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Miguel Guzmán
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - José Manuel Zubeldia
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute, Madrid, Spain; Biomedical Research Network on Rare Diseases (CIBERER)-U761, Madrid, Spain
| | - María L Baeza
- Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Gregorio Marañón Health Research Institute, Madrid, Spain; Biomedical Research Network on Rare Diseases (CIBERER)-U761, Madrid, Spain
| |
Collapse
|
32
|
Lucero D, Olano C, Bursztyn M, Morales C, Stranges A, Friedman S, Macri EV, Schreier L, Zago V. Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: does it improve VLDL quality? Food Funct 2017; 8:2053-2061. [DOI: 10.1039/c7fo00252a] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Could supplementation with n-3, n-6 and n-9 fatty acids prevent atherogenic alterations of VLDL produced in insulin-resistance?
Collapse
Affiliation(s)
- D. Lucero
- Universidad de Buenos Aires
- Facultad de Farmacia y Bioquímica
- Departamento de Bioquímica Clínica
- Laboratorio de Lípidos y Aterosclerosis
- Buenos Aires
| | - C. Olano
- Universidad de Buenos Aires
- Facultad de Farmacia y Bioquímica
- Departamento de Bioquímica Clínica
- Laboratorio de Lípidos y Aterosclerosis
- Buenos Aires
| | - M. Bursztyn
- Universidad de Buenos Aires
- Facultad de Farmacia y Bioquímica
- Departamento de Bioquímica Clínica
- Laboratorio de Lípidos y Aterosclerosis
- Buenos Aires
| | - C. Morales
- Universidad de Buenos Aires
- Facultad de Medicina
- Instituto de Fisiopatología Cardiovascular (INFICA)
- Buenos Aires
- Argentina
| | - A. Stranges
- Universidad de Buenos Aires
- Facultad de Odontología
- Cátedra de Bioquímica General y Bucal
- Buenos Aires
- Argentina
| | - S. Friedman
- Universidad de Buenos Aires
- Facultad de Odontología
- Cátedra de Bioquímica General y Bucal
- Buenos Aires
- Argentina
| | - E. V. Macri
- Universidad de Buenos Aires
- Facultad de Odontología
- Cátedra de Bioquímica General y Bucal
- Buenos Aires
- Argentina
| | - L. Schreier
- Universidad de Buenos Aires
- Facultad de Farmacia y Bioquímica
- Departamento de Bioquímica Clínica
- Laboratorio de Lípidos y Aterosclerosis
- Buenos Aires
| | - V. Zago
- Universidad de Buenos Aires
- Facultad de Farmacia y Bioquímica
- Departamento de Bioquímica Clínica
- Laboratorio de Lípidos y Aterosclerosis
- Buenos Aires
| |
Collapse
|
33
|
Haba J, Ruiz A, Pollan M, Prat A, Rojo F, Martin M, Conejo EA, Perez-Fidalgo J, Gavilá J, Morales C, Navarro B, Hernández-Blanquisett A, Porras I, Rodriguez-Lescure A, Jiménez-Rodríguez B, Martín N, Pérez-Ramos L, Caballero R, Carrasco E, Lluch-Hernandez A. Gestational breast cancer: distinctive molecular and clinico-epidemiological features. GEICAM/2012-03 study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw364.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Martín-Campos J, Julve J, Plana N, Figueras R, Esteve E, Mauri M, Bueno M, Caixàs A, Llargués E, Vila À, Morales C, Soler C, Argimón J, Mayos J, Grau J, Zamora A, Matas L, Vila L, Masana L, Blanco-Vaca F. Low-density lipoprotein gene score to identify polygenic forms of familial hypercholesterolemia in a Spanish population. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.342] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Morales C, Flores E, Bodega J, Leardini F, Ferrer IJ, Ares JR, Sánchez C. On the van der Pauw's method applied to the measurement of low thermal conductivity materials. Rev Sci Instrum 2016; 87:084902. [PMID: 27587145 DOI: 10.1063/1.4960331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
The electrical van der Pauw's method has recently been extended to measure the thermal conductivity of different elements and compounds. This technique provides an easy way to determine the sample in-plane thermal conductivity by avoiding the influence of the thermal contact resistances. However, the reported calculated error values appear to be underestimated when dealing with the materials with low thermal conductivity (<5 W/Km) at room temperature. The causes of this underestimation are investigated in this communication and it has been found that they are due to the drastic influence of conduction heat losses through the thermo-resistance wires as well as the resulting modification of the sample temperature map. Both phenomena lead to experimental values of the sample thermal conductivity, which are systematically higher than the tabulated ones. The magnitude of this systematic error is ∼100% dealing with the samples of macroscopic dimensions, and low thermal conductivity indicated that the obtained accurate measurements can be quite challenging.
Collapse
Affiliation(s)
- C Morales
- Departamento Física Aplicada, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - E Flores
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - J Bodega
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - F Leardini
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - I J Ferrer
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - J R Ares
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| | - C Sánchez
- Departamento Física de Materiales, Universidad Autónoma de Madrid, Madrid 28049, Spain
| |
Collapse
|
36
|
Pineda R, Rojas P, Martínez P, Zambrano G, Morales C, de Barrio M. Erythrodysestesia-like skin eruption due to docetaxel with a nonimmediate positive intradermal skin test result. The Journal of Allergy and Clinical Immunology: In Practice 2016; 4:341-2. [DOI: 10.1016/j.jaip.2015.10.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Revised: 10/12/2015] [Accepted: 10/22/2015] [Indexed: 10/22/2022]
|
37
|
Noguerado B, Rojas P, Calderon M, Morales C, Tornero P. Allergy to Benznidazole: Cross-Reactivity with Other Nitroimidazoles. J Allergy Clin Immunol 2016. [DOI: 10.1016/j.jaci.2015.12.151] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Abstract
Prostate cancer is very frequent, but secondary ureteral metastasis are extremely rare. We present a 55 year old man with a 2 month history of right flank pain and lower urinary tract symptoms. Prostatic specific antigen of 11.3 ng/mL. Computed tomography showed right hydroureteronephrosis, a developing urinoma and right iliac adenopathies. He underwent right ureteronephrectomy, iliac lymphadenectomy and prostate biopsy. Pathology revealed prostatic carcinoma infiltrating the ureteral muscularis propria, without mucosal involvement. There are 46 reported cases of prostate cancer with ureteral metastases. Ureteral metastasis are a rare cause of renal colic and need of a high index of suspicion.
Collapse
Affiliation(s)
- I Morales
- Department of Surgery, Universidad de los Andes, Santiago, Región Metropolitana, Chile
| | - C Bassa
- School of Medicine, Universidad de los Andes, Santiago, Región Metropolitana, Chile
| | - A Pavlovic
- Department of Public Health, Universidad de los Andes, Santiago, Región Metropolitana, Chile
| | - C Morales
- Department of Surgery, Universidad de los Andes, Santiago, Región Metropolitana, Chile
| |
Collapse
|
39
|
Barranco RJ, Gomez-Peralta F, Abreu C, Delgado M, Palomares R, Romero F, Morales C, de la Cal MA, Garcia-Almeida JM, Pasquel F, Umpierrez GE. Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project. Diabet Med 2015; 32:1520-6. [PMID: 26118472 PMCID: PMC4755037 DOI: 10.1111/dme.12843] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/23/2015] [Indexed: 12/31/2022]
Abstract
AIMS Hypoglycaemia is a serious medical emergency. The need for emergency medical service care and the costs of hypoglycaemic emergencies are not completely known. METHODS This was a retrospective observational study using Public Company for Health Emergencies (EPES) data for hypoglycaemia in 2012. The EPES provides emergency medical services to the entire population of Andalusia, Spain (8.5 million people). Data on event type, onsite treatments, emergency room visits or hospitalization were collected. Medical costs were estimated using the public rates for healthcare services. RESULTS From a total of 1 137 738 emergency calls that requested medical assistance, 8683 had a primary diagnosis of hypoglycaemia (10.34 per 10 000 person-years). The incidence of severe hypoglycaemic episodes requiring emergency treatment in the estimated population with diabetes was 80 episodes per 10 000 person-years. A total of 7479 episodes (86%) required an emergency team to visit the patient's residence. The majority of cases (64%) were addressed in the residence, although 1784 (21%) cases were transferred to hospital. A total of 5564 events (65%) involved patients aged > 65 years. Overall mortality was 0.32% (28 cases). The total annual cost of attending a hypoglycaemic episode was €6 093 507, leading to an estimated mean direct cost per episode of €702 ± 565. Episodes that required hospital treatment accounted for 49% of the total costs. CONCLUSIONS Hypoglycaemia is a common medical emergency that is associated with high emergency medical service utilization, resulting in a significant economic impact on the health system.
Collapse
Affiliation(s)
- R J Barranco
- Public Company for Health Emergencies of Andalucıa (EPES), Sevilla, Spain
- Department Health Sciences, University of Jaen, Segovia, Spain
| | - F Gomez-Peralta
- Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain
| | - C Abreu
- Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain
| | - M Delgado
- Division of Preventive Medicine and Public Health, Department Health Sciences, University of Jaen, Jaen, Spain
- Center for Biomedical Research in Epidemiology and Public Health (CIBERESP), ISCIII, Ministry of Health, Madrid, Spain
| | - R Palomares
- Endocrinology and Nutrition Unit, Reina Sofia Hospital, Cordoba, Spain
| | - F Romero
- Public Company for Health Emergencies of Andalucıa (EPES), Sevilla, Spain
| | - C Morales
- Endocrinology and Nutrition Unit, Virgen Macarena Hospital, Sevilla, Spain
| | - M A de la Cal
- Public Company for Health Emergencies of Andalucıa (EPES), Sevilla, Spain
| | - J M Garcia-Almeida
- Endocrinology and Clinical Nutrition Unit, Virgen de la Victoria Hospital, Malaga, Spain
| | - F Pasquel
- Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
| | - G E Umpierrez
- Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
| |
Collapse
|
40
|
Andrades J, Campanini J, Vásquez D, Silvestri C, Morales C, Romero J, Mella J. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus. SAR QSAR Environ Res 2015; 26:925-942. [PMID: 26505124 DOI: 10.1080/1062936x.2015.1095798] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
A major problem today is bacterial resistance to antibiotics and the small number of new therapeutic agents approved in recent years. The development of new antibiotics capable of acting on new targets is urgently required. The filamenting temperature-sensitive Z (FtsZ) bacterial protein is a key biomolecule for bacterial division and survival. This makes FtsZ an attractive new pharmacological target for the development of antibacterial agents. There have been several attempts to develop ligands able to inhibit FtsZ. Despite the large number of synthesized compounds that inhibit the FtsZ protein, there are no quantitative structure-activity relationships (QSAR) that allow for the rational design and synthesis of promising new molecules. We present the first 3D-QSAR study of a large and diverse set of molecules that are able to inhibit the FtsZ bacterial protein. We summarize a set of chemical changes that can be made in the steric, electrostatic, hydrophobic and donor/acceptor hydrogen-bonding properties of the pharmacophore, to generate new bioactive molecules against FtsZ. These results provide a rational guide for the design and synthesis of promising new antibacterial agents, supported by the strong statistical parameters obtained from CoMFA (r(2)(pred) = 0.974) and CoMSIA (r(2)(pred) = 0.980) analyses.
Collapse
Affiliation(s)
- J Andrades
- a Departamento de Química Farmacológica y Toxicológica , Universidad de Chile , Santiago , Chile
| | - J Campanini
- a Departamento de Química Farmacológica y Toxicológica , Universidad de Chile , Santiago , Chile
| | - D Vásquez
- a Departamento de Química Farmacológica y Toxicológica , Universidad de Chile , Santiago , Chile
| | - C Silvestri
- b Department of Bioengineering , Imperial College London , London , England
| | - C Morales
- c Departamento de Ciencias Químicas y Biológicas , Universidad Bernardo O Higgins , Santiago , Chile
| | - J Romero
- d Department of Pharmacy , Pontificia Universidad Católica de Chile , Santiago , Chile
| | - J Mella
- e Instituto de Química y Bioquímica, Universidad de Valparaíso , Valparaíso , Chile
| |
Collapse
|
41
|
Martín M, González-Rivera M, Morales S, de la Haba-Rodriguez J, González-Cortijo L, Manso L, Albanell J, González-Martín A, González S, Arcusa A, de la Cruz-Merino L, Rojo F, Vidal M, Galván P, Aguirre E, Morales C, Ferree S, Pompilio K, Casas M, Caballero R, Goicoechea U, Carrasco E, Michalopoulos S, Hornberger J, Prat A. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer. Curr Med Res Opin 2015; 31:1129-37. [PMID: 25851308 DOI: 10.1185/03007995.2015.1037730] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
PURPOSE Improved understanding of risk of recurrence (ROR) is needed to reduce cases of recurrence and more effectively treat breast cancer patients. The purpose of this study was to examine how a gene-expression profile (GEP), identified by Prosigna, influences physician adjuvant treatment selection for early breast cancer (EBC) and the effects of this influence on optimizing adjuvant treatment recommendations in clinical practice. METHODS A prospective, observational, multicenter study was carried out in 15 hospitals across Spain. Participating medical oncologists completed pre-assessment, post-assessment, and follow-up questionnaires recording their treatment recommendations and confidence in these recommendations, before and after knowing the patient's ROR. Patients completed questionnaires on decision-making, anxiety, and health status. RESULTS Between June 2013 and January 2014, 217 patients enrolled and a final 200 were included in the study. Patients were postmenopausal, estrogen receptor positive, human epidermal growth hormone factor negative, and node negative with either stage 1 or stage 2 tumors. After receiving the GEP results, treatment recommendations were changed for 40 patients (20%). The confidence of medical oncologists in their treatment recommendations increased in 41.6% and decreased in 6.5% of total cases. Patients reported lower anxiety after physicians made treatment recommendations based on the GEP results (p < 0.05). CONCLUSIONS Though this study does not include evaluation of the impact of GEP on long-term outcomes, it was found that GEP results influenced the treatment decisions of medical oncologists and their confidence in adjuvant therapy selection. Patients' anxiety about the selected adjuvant therapy decreased with use of the GEP.
Collapse
Affiliation(s)
- Miguel Martín
- Department of Medical Oncology, Hospital Gregorio Marañón , Madrid , Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Morales C, Micozzi S, de Santa Maria MS, Baeza Ochoa de Ocaríz ML. Omalizumab in Chronic Urticaria: Experience in a Third Level Hospital in Madrid. J Allergy Clin Immunol 2015. [DOI: 10.1016/j.jaci.2014.12.1351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
43
|
Ameiro B, Zambrano GA, Guzmán M, Morales C, Noguerado B, Baeza ML, Alvarez-Perea A. Causes of Anaphylaxis in the Pediatric Population. J Allergy Clin Immunol 2015. [DOI: 10.1016/j.jaci.2014.12.1614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Morales C, Held CM, Estevez PA, Perez CA, Reyes S, Peirano P, Algarin C. Single trial P300 detection in children using expert knowledge and SOM. Annu Int Conf IEEE Eng Med Biol Soc 2015; 2014:3801-4. [PMID: 25570819 DOI: 10.1109/embc.2014.6944451] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Preliminary results of an automatic system for single trial P300 visual evoked potential events detection are presented. For each single trial P300, several candidate events were generated, and then filtered, using 3 wave features. The surviving candidate events were fed into a SOM-based classifier. A context filter was applied before the final output. No stationary condition of the P300 is involved in the algorithms. Recordings of 27 assessment sessions, each with 120 trials, were visually inspected by experts to identify and mark the P300 events, which was accomplished in about one third of the trials. The dataset was divided in training (18) and testing (9) subsets. The system identifies the initial and end times of the P300; it obtained a sensitivity of 53.9%, a specificity of 64.0% and an accuracy of 61.2% in the testing dataset.
Collapse
|
45
|
Ramírez DAA, Morales C, De LD, Ferrario MG, Lizán L. Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain. Value Health 2014; 17:A343. [PMID: 27200637 DOI: 10.1016/j.jval.2014.08.686] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - C Morales
- Hospital Virgen de la Macarena, Sevilla, Spain
| | - Luis D De
- Hospital Rio Hortega, Valladolid, Spain
| | | | - L Lizán
- Outcomes 10, Castellon, Spain
| |
Collapse
|
46
|
Ramírez DAA, Lizán L, Prades M, Morales C, De LD. Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 1 Diabetes Mellitus In Spain. Value Health 2014; 17:A343. [PMID: 27200636 DOI: 10.1016/j.jval.2014.08.687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - L Lizán
- Outcomes 10, Castellon, Spain
| | | | - C Morales
- Hospital Virgen de la Macarena, Sevilla, Spain
| | - Luis D De
- Hospital Rio Hortega, Valladolid, Spain
| |
Collapse
|
47
|
Plana N, Figueras R, Esteve E, Mauri M, Bueno M, Caixàs A, Llargués E, Vila A, Morales C, Soler C, Argimon J, Mayos J, Grau J, Zamora A, Matas L, Vila L, Blanco-Vaca F. Use of next generation sequencing for the diagnosis of familial hypercholesterolemia. Atherosclerosis 2014. [DOI: 10.1016/j.atherosclerosis.2014.05.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Miksztowicz V, Morales C, Zago V, Friedman S, Schreier L, Berg G. Effect of insulin-resistance on circulating and adipose tissue MMP-2 and MMP-9 activity in rats fed a sucrose-rich diet. Nutr Metab Cardiovasc Dis 2014; 24:294-300. [PMID: 24418386 DOI: 10.1016/j.numecd.2013.08.007] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2013] [Revised: 07/05/2013] [Accepted: 08/03/2013] [Indexed: 02/07/2023]
Abstract
BACKGROUND AND AIM Adipose tissue produces different metalloproteinases (MMPs), involved in adipogenesis and angiogenesis. Different studies have shown that in obesity the behavior of different MMPs may be altered. However there are scarce data about the effect of insulin-resistance (IR) on MMP-2 and MMP-9 activity in adipose tissue. Our aim was to determine whether sucrose induced IR modifies MMP-2 and MMP-9 behavior in expanded visceral adipose tissue and the contribution of this tissue to circulating activity of these gelatinases. METHODS AND RESULTS Male Wistar rats were fed with standard diet (Control) or standard diet plus 30% sucrose in the drinking water throughout 12 weeks (SRD). In epididymal adipose tissue vascular density, size and adipocyte density, PPARγ expression and MMP-2 and -9 were measured. Adipose tissue from SRD presented higher adipocyte size (6.32 ± 8.71 vs 4.33 ± 2.17 × 10(3) μm(2), p = 0.001) lower adipocyte density (164 (130-173) vs 190 (170-225) number/mm(2), p = 0.046) and lower vascular density (16.2 (12.8-23.5) vs 28.1 (22.3-46.5) blood vessels/mm(2), p = 0.002) than Control. MMP-2 and MMP-9 activity was decreased in SRD (1.93 ± 0.7 vs 3.92 ± 0.9 relative units, p = 0.048 and 1.80 ± 0.8 vs 5.13 ± 1.7 relative units, p = 0.004 respectively) in accordance with lower protein expression (0.35 ± 0.20 vs 2.71 ± 0.48 relative units, p = 0.004 and 1.12 ± 0.21 vs 1.52 ± 0.05 relative units, p = 0.036 respectively). There were no differences in PPARγ expression between groups. CONCLUSION Insulin resistance induced by SRD decreases MMP-2 and MMP-9 activity in adipose tissue which would not represent an important source for circulating MMP-2 and -9. In this state of IR, PPARγ would not be involved in the negative regulation of adipose tissue gelatinases.
Collapse
Affiliation(s)
- V Miksztowicz
- Laboratory of Lipids and Lipoproteins, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, Buenos Aires, Argentina
| | - C Morales
- Institute of Cardiovascular Physiopathology and Department of Pathology, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina
| | - V Zago
- Laboratory of Lipids and Lipoproteins, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, Buenos Aires, Argentina
| | - S Friedman
- Oral and General Biochemistry Department, Faculty of Dentistry, University of Buenos Aires, Buenos Aires, Argentina
| | - L Schreier
- Laboratory of Lipids and Lipoproteins, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, Buenos Aires, Argentina
| | - G Berg
- Laboratory of Lipids and Lipoproteins, Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, Buenos Aires, Argentina.
| |
Collapse
|
49
|
Ameiro B, Noguerado B, Zambrano G, Morales C, Guzmán M, Baeza ML, Alvarez-Perea A. Characteristics Of Anaphylaxis In a Pediatric Emergency Unit. J Allergy Clin Immunol 2014. [DOI: 10.1016/j.jaci.2013.12.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
50
|
Reina J, Weber I, Riera E, Busquets M, Morales C. [Usefulness of a real-time quantitative polymerase-chain reaction (PCR) assay for the diagnosis of congenital and postnatal cytomegalovirus infection]. An Pediatr (Barc) 2013; 80:299-303. [PMID: 24103236 DOI: 10.1016/j.anpedi.2013.06.036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Revised: 06/25/2013] [Accepted: 06/30/2013] [Indexed: 10/26/2022] Open
Abstract
INTRODUCTION Cytomegalovirus (CMV) is the main virus causing congenital and postnatal infections in the pediatric population. The aim of this study is to evaluate the usefulness of a quantitative real-time PCR in the diagnosis of these infections using urine as a single sample. PATIENTS AND METHODS We studied all the urine samples of newborns (< 7 days) with suspected congenital infection, and urine of patients with suspected postnatal infection (urine negative at birth). Urines were simultaneously studied by cell culture, qualitative PCR (PCRc), and quantitative real-time PCR (PCRq). RESULTS We analyzed 332 urine samples (270 to rule out congenital infection and 62 postnatal infections). Of the first, 22 were positive in the PCRq, 19 in the PCRc, and 17 in the culture. PCRq had a sensitivity of 100%, on comparing the culture with the rest of the techniques. Using the PCRq as a reference method, culture had a sensitivity of 77.2%, and PCRc 86.3%. In cases of postnatal infection, PCRq detected 16 positive urines, the PCRq 12, and the cell culture 10. The urines showed viral loads ranging from 2,178 to 116,641 copies/ml. CONCLUSIONS The genomic amplification technique PCRq in real time was more sensitive than the other techniques evaluated. This technique should be considered as a reference (gold standard), leaving the cell culture as a second diagnostic level. The low cost and the automation of PCRq would enable the screening for CMV infection in large neonatal and postnatal populations.
Collapse
Affiliation(s)
- J Reina
- Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España.
| | - I Weber
- Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España
| | - E Riera
- Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España
| | - M Busquets
- Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España
| | - C Morales
- Unidad de Virología, Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España
| |
Collapse
|